 Shawn St Peter
Concepts (936)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Laparoscopy | 98 | 2021 | 220 | 24.880 |
Why?
| | Appendicitis | 59 | 2022 | 122 | 21.520 |
Why?
| | Appendectomy | 50 | 2022 | 105 | 17.370 |
Why?
| | Humans | 393 | 2022 | 5729 | 14.990 |
Why?
| | Retrospective Studies | 210 | 2022 | 1105 | 13.140 |
Why?
| | Male | 248 | 2021 | 3249 | 11.920 |
Why?
| | Child | 240 | 2022 | 2689 | 11.630 |
Why?
| | Female | 246 | 2021 | 3314 | 11.410 |
Why?
| | Postoperative Complications | 61 | 2021 | 163 | 10.160 |
Why?
| | Funnel Chest | 23 | 2020 | 52 | 10.150 |
Why?
| | Child, Preschool | 133 | 2021 | 1479 | 8.380 |
Why?
| | Treatment Outcome | 107 | 2022 | 598 | 7.860 |
Why?
| | Adolescent | 141 | 2021 | 1938 | 7.780 |
Why?
| | Pain, Postoperative | 18 | 2021 | 38 | 7.780 |
Why?
| | Fundoplication | 21 | 2020 | 38 | 7.510 |
Why?
| | Wounds, Nonpenetrating | 28 | 2022 | 55 | 7.220 |
Why?
| | Infant | 122 | 2021 | 1365 | 7.160 |
Why?
| | Prospective Studies | 76 | 2022 | 458 | 7.120 |
Why?
| | Gastroesophageal Reflux | 18 | 2020 | 44 | 6.860 |
Why?
| | Abdominal Abscess | 15 | 2021 | 29 | 6.810 |
Why?
| | Anti-Bacterial Agents | 27 | 2021 | 226 | 6.470 |
Why?
| | Surgical Wound Infection | 21 | 2021 | 45 | 6.110 |
Why?
| | Tomography, X-Ray Computed | 40 | 2021 | 116 | 5.910 |
Why?
| | Analgesia, Patient-Controlled | 12 | 2019 | 21 | 5.660 |
Why?
| | Infant, Newborn | 90 | 2021 | 863 | 5.150 |
Why?
| | Length of Stay | 50 | 2021 | 220 | 4.910 |
Why?
| | Follow-Up Studies | 54 | 2020 | 310 | 4.750 |
Why?
| | Postoperative Care | 13 | 2020 | 29 | 4.510 |
Why?
| | Thoracoscopy | 17 | 2021 | 31 | 4.440 |
Why?
| | Foreign Bodies | 9 | 2021 | 25 | 4.360 |
Why?
| | Liver | 21 | 2020 | 155 | 4.130 |
Why?
| | Spleen | 15 | 2020 | 26 | 4.100 |
Why?
| | Cholecystectomy, Laparoscopic | 11 | 2021 | 28 | 3.900 |
Why?
| | Drainage | 16 | 2021 | 39 | 3.880 |
Why?
| | Esophagus | 12 | 2020 | 34 | 3.560 |
Why?
| | Empyema, Pleural | 6 | 2021 | 10 | 3.470 |
Why?
| | Minimally Invasive Surgical Procedures | 17 | 2020 | 35 | 3.420 |
Why?
| | Enteral Nutrition | 13 | 2020 | 55 | 3.370 |
Why?
| | Randomized Controlled Trials as Topic | 12 | 2020 | 64 | 3.280 |
Why?
| | Pyloric Stenosis, Hypertrophic | 7 | 2016 | 9 | 3.230 |
Why?
| | Gastrostomy | 12 | 2020 | 59 | 3.220 |
Why?
| | Pediatrics | 19 | 2020 | 192 | 3.220 |
Why?
| | Hernias, Diaphragmatic, Congenital | 10 | 2016 | 24 | 3.200 |
Why?
| | Gastroschisis | 10 | 2021 | 27 | 3.170 |
Why?
| | Hernia, Inguinal | 12 | 2021 | 24 | 3.130 |
Why?
| | Esophageal Atresia | 13 | 2020 | 35 | 2.970 |
Why?
| | Hospitals, Pediatric | 18 | 2021 | 174 | 2.910 |
Why?
| | Practice Patterns, Physicians' | 12 | 2021 | 85 | 2.910 |
Why?
| | Tracheoesophageal Fistula | 10 | 2020 | 30 | 2.800 |
Why?
| | Digestive System Surgical Procedures | 12 | 2019 | 45 | 2.770 |
Why?
| | Abdominal Injuries | 13 | 2022 | 22 | 2.680 |
Why?
| | Intussusception | 7 | 2020 | 15 | 2.660 |
Why?
| | Analgesia, Epidural | 4 | 2019 | 12 | 2.640 |
Why?
| | Ceftriaxone | 7 | 2015 | 17 | 2.550 |
Why?
| | Clinical Protocols | 10 | 2018 | 35 | 2.540 |
Why?
| | Pyloric Stenosis | 6 | 2016 | 12 | 2.530 |
Why?
| | Time Factors | 30 | 2019 | 276 | 2.520 |
Why?
| | Wounds and Injuries | 5 | 2018 | 51 | 2.410 |
Why?
| | Tissue Plasminogen Activator | 4 | 2020 | 5 | 2.350 |
Why?
| | Pneumothorax | 10 | 2021 | 25 | 2.250 |
Why?
| | Herniorrhaphy | 9 | 2021 | 19 | 2.220 |
Why?
| | Anesthesia, Epidural | 4 | 2015 | 4 | 2.180 |
Why?
| | Surgical Mesh | 6 | 2012 | 8 | 2.080 |
Why?
| | Sutures | 4 | 2020 | 10 | 2.010 |
Why?
| | Metronidazole | 6 | 2015 | 15 | 1.990 |
Why?
| | Crohn Disease | 4 | 2014 | 21 | 1.930 |
Why?
| | Laparotomy | 12 | 2021 | 25 | 1.930 |
Why?
| | Suture Techniques | 6 | 2020 | 11 | 1.910 |
Why?
| | Catheterization, Central Venous | 6 | 2016 | 18 | 1.900 |
Why?
| | Reoperation | 18 | 2020 | 53 | 1.880 |
Why?
| | Algorithms | 11 | 2021 | 95 | 1.860 |
Why?
| | Abdominal Pain | 5 | 2019 | 72 | 1.820 |
Why?
| | Intestinal Obstruction | 8 | 2019 | 21 | 1.820 |
Why?
| | Hernia, Hiatal | 5 | 2015 | 7 | 1.810 |
Why?
| | Suction | 5 | 2015 | 9 | 1.790 |
Why?
| | United States | 31 | 2020 | 594 | 1.780 |
Why?
| | General Surgery | 8 | 2016 | 21 | 1.760 |
Why?
| | Cicatrix | 3 | 2016 | 3 | 1.720 |
Why?
| | Pylorus | 7 | 2015 | 12 | 1.720 |
Why?
| | Hernia, Diaphragmatic | 8 | 2012 | 17 | 1.690 |
Why?
| | Esophagoscopy | 5 | 2020 | 12 | 1.680 |
Why?
| | Operative Time | 12 | 2019 | 28 | 1.650 |
Why?
| | Umbilicus | 5 | 2018 | 11 | 1.630 |
Why?
| | Peritoneal Lavage | 3 | 2015 | 6 | 1.630 |
Why?
| | Hirschsprung Disease | 7 | 2021 | 49 | 1.620 |
Why?
| | Cryosurgery | 2 | 2019 | 10 | 1.570 |
Why?
| | Costal Cartilage | 2 | 2021 | 4 | 1.570 |
Why?
| | Fibrinolytic Agents | 4 | 2015 | 5 | 1.560 |
Why?
| | Severity of Illness Index | 7 | 2018 | 145 | 1.550 |
Why?
| | Trauma Centers | 14 | 2022 | 36 | 1.540 |
Why?
| | Urinary Retention | 4 | 2018 | 5 | 1.530 |
Why?
| | Enterocolitis, Necrotizing | 11 | 2021 | 64 | 1.520 |
Why?
| | Specialties, Surgical | 6 | 2016 | 14 | 1.480 |
Why?
| | Ileum | 3 | 2014 | 23 | 1.470 |
Why?
| | Circumcision, Male | 2 | 2018 | 3 | 1.470 |
Why?
| | Evidence-Based Medicine | 8 | 2014 | 42 | 1.460 |
Why?
| | Kidney | 5 | 2013 | 88 | 1.450 |
Why?
| | Intestinal Volvulus | 5 | 2019 | 15 | 1.440 |
Why?
| | Thoracic Surgery, Video-Assisted | 5 | 2020 | 10 | 1.440 |
Why?
| | Abscess | 5 | 2014 | 12 | 1.430 |
Why?
| | Gallbladder Diseases | 4 | 2016 | 13 | 1.430 |
Why?
| | Cryptorchidism | 3 | 2016 | 7 | 1.410 |
Why?
| | Ribs | 3 | 2021 | 6 | 1.400 |
Why?
| | Risk Factors | 22 | 2021 | 398 | 1.390 |
Why?
| | Radiography, Thoracic | 5 | 2017 | 14 | 1.380 |
Why?
| | Bed Rest | 5 | 2013 | 10 | 1.320 |
Why?
| | Intestinal Perforation | 7 | 2021 | 13 | 1.320 |
Why?
| | Quality Improvement | 6 | 2018 | 63 | 1.320 |
Why?
| | Databases, Factual | 8 | 2021 | 103 | 1.310 |
Why?
| | Adult | 22 | 2016 | 1075 | 1.300 |
Why?
| | Ileal Diseases | 3 | 2018 | 8 | 1.300 |
Why?
| | Thrombolytic Therapy | 2 | 2021 | 5 | 1.290 |
Why?
| | Hernia, Umbilical | 5 | 2019 | 8 | 1.270 |
Why?
| | Cholelithiasis | 3 | 2015 | 7 | 1.270 |
Why?
| | Fluoroscopy | 7 | 2020 | 18 | 1.260 |
Why?
| | Obesity | 3 | 2012 | 108 | 1.260 |
Why?
| | Radiography | 8 | 2018 | 41 | 1.260 |
Why?
| | Appendix | 4 | 2018 | 11 | 1.260 |
Why?
| | Esophageal Achalasia | 2 | 2016 | 4 | 1.260 |
Why?
| | Patient Discharge | 7 | 2020 | 53 | 1.250 |
Why?
| | Preoperative Care | 11 | 2020 | 26 | 1.240 |
Why?
| | Pain Measurement | 7 | 2019 | 44 | 1.240 |
Why?
| | Incidence | 27 | 2020 | 132 | 1.220 |
Why?
| | Biliary Dyskinesia | 4 | 2019 | 8 | 1.200 |
Why?
| | Blood Transfusion | 6 | 2017 | 16 | 1.190 |
Why?
| | Recurrence | 17 | 2021 | 103 | 1.190 |
Why?
| | Unnecessary Procedures | 3 | 2020 | 16 | 1.190 |
Why?
| | Electric Power Supplies | 2 | 2021 | 4 | 1.150 |
Why?
| | Esophageal Perforation | 2 | 2017 | 4 | 1.120 |
Why?
| | Liver Transplantation | 6 | 2004 | 35 | 1.120 |
Why?
| | Combined Modality Therapy | 11 | 2018 | 51 | 1.110 |
Why?
| | Orthopedic Procedures | 5 | 2018 | 17 | 1.110 |
Why?
| | Urinary Catheterization | 4 | 2018 | 5 | 1.100 |
Why?
| | Biomedical Research | 4 | 2018 | 26 | 1.090 |
Why?
| | Thoracic Surgical Procedures | 5 | 2011 | 10 | 1.090 |
Why?
| | Ambulatory Surgical Procedures | 5 | 2018 | 15 | 1.090 |
Why?
| | Histamine H2 Antagonists | 3 | 2017 | 8 | 1.060 |
Why?
| | Catheterization | 4 | 2016 | 25 | 1.030 |
Why?
| | Age Factors | 12 | 2021 | 227 | 1.030 |
Why?
| | Enema | 6 | 2020 | 12 | 1.030 |
Why?
| | Cecum | 2 | 2014 | 5 | 1.020 |
Why?
| | Stomach | 3 | 2018 | 16 | 1.020 |
Why?
| | Patient Satisfaction | 10 | 2019 | 39 | 1.010 |
Why?
| | Clinical Trials as Topic | 4 | 2018 | 48 | 0.990 |
Why?
| | Surveys and Questionnaires | 12 | 2020 | 253 | 0.990 |
Why?
| | Intestine, Small | 6 | 2014 | 18 | 0.980 |
Why?
| | Antibiotic Prophylaxis | 8 | 2021 | 30 | 0.980 |
Why?
| | Esophagoplasty | 3 | 2020 | 4 | 0.980 |
Why?
| | Clinical Decision-Making | 3 | 2021 | 21 | 0.980 |
Why?
| | Splenectomy | 5 | 2017 | 10 | 0.960 |
Why?
| | Pancreas | 4 | 2017 | 9 | 0.960 |
Why?
| | Intubation, Gastrointestinal | 5 | 2018 | 20 | 0.950 |
Why?
| | Risk Assessment | 12 | 2019 | 135 | 0.940 |
Why?
| | Equipment Contamination | 2 | 2021 | 6 | 0.930 |
Why?
| | Perioperative Care | 2 | 2018 | 11 | 0.930 |
Why?
| | Injury Severity Score | 13 | 2022 | 52 | 0.910 |
Why?
| | Prognosis | 15 | 2019 | 180 | 0.910 |
Why?
| | Fomites | 1 | 2021 | 2 | 0.900 |
Why?
| | Electrical Equipment and Supplies | 1 | 2021 | 2 | 0.900 |
Why?
| | Surgical Attire | 1 | 2021 | 2 | 0.900 |
Why?
| | Protective Clothing | 1 | 2021 | 4 | 0.900 |
Why?
| | Critical Pathways | 3 | 2018 | 10 | 0.900 |
Why?
| | Colitis, Ulcerative | 2 | 2011 | 7 | 0.900 |
Why?
| | Birth Weight | 7 | 2018 | 30 | 0.890 |
Why?
| | Numismatics | 1 | 2020 | 5 | 0.890 |
Why?
| | Pneumoperitoneum, Artificial | 2 | 2011 | 6 | 0.890 |
Why?
| | Heart Defects, Congenital | 4 | 2018 | 67 | 0.890 |
Why?
| | Organ Preservation | 5 | 2003 | 6 | 0.880 |
Why?
| | Respiratory Insufficiency | 3 | 2019 | 15 | 0.880 |
Why?
| | Intraoperative Care | 3 | 2018 | 6 | 0.860 |
Why?
| | Young Adult | 11 | 2021 | 573 | 0.850 |
Why?
| | Biocompatible Materials | 2 | 2012 | 2 | 0.850 |
Why?
| | Ultrasonography | 10 | 2019 | 42 | 0.850 |
Why?
| | Diagnostic Imaging | 2 | 2017 | 11 | 0.840 |
Why?
| | Guideline Adherence | 1 | 2020 | 35 | 0.840 |
Why?
| | Burns | 4 | 2014 | 17 | 0.820 |
Why?
| | Surgical Procedures, Operative | 5 | 2020 | 13 | 0.820 |
Why?
| | Sensitivity and Specificity | 10 | 2018 | 145 | 0.810 |
Why?
| | Tissue Adhesions | 2 | 2017 | 5 | 0.800 |
Why?
| | Thoracotomy | 2 | 2018 | 10 | 0.800 |
Why?
| | Medical Errors | 1 | 2019 | 7 | 0.800 |
Why?
| | Chest Tubes | 6 | 2021 | 16 | 0.800 |
Why?
| | Pericardium | 2 | 2011 | 6 | 0.790 |
Why?
| | Thoracostomy | 4 | 2021 | 8 | 0.790 |
Why?
| | Research Design | 2 | 2018 | 55 | 0.780 |
Why?
| | Child Abuse | 2 | 2018 | 49 | 0.780 |
Why?
| | Drug Therapy, Combination | 7 | 2018 | 43 | 0.770 |
Why?
| | Data Interpretation, Statistical | 1 | 2018 | 18 | 0.770 |
Why?
| | Orchiopexy | 2 | 2015 | 5 | 0.770 |
Why?
| | Sodium Chloride | 2 | 2016 | 3 | 0.770 |
Why?
| | Testis | 2 | 2015 | 6 | 0.770 |
Why?
| | Hypertension, Pulmonary | 2 | 2017 | 12 | 0.760 |
Why?
| | Pleural Effusion | 3 | 2016 | 5 | 0.760 |
Why?
| | Intercostal Nerves | 1 | 2018 | 3 | 0.760 |
Why?
| | Phimosis | 1 | 2018 | 1 | 0.760 |
Why?
| | Neuromuscular Diseases | 1 | 2018 | 3 | 0.750 |
Why?
| | Lung Diseases | 1 | 2018 | 38 | 0.750 |
Why?
| | Colonic Diseases | 3 | 2014 | 5 | 0.750 |
Why?
| | Malnutrition | 1 | 2018 | 10 | 0.740 |
Why?
| | Acute Disease | 6 | 2020 | 63 | 0.740 |
Why?
| | Tissue Adhesives | 2 | 2017 | 3 | 0.740 |
Why?
| | Cohort Studies | 12 | 2021 | 250 | 0.740 |
Why?
| | Extracorporeal Membrane Oxygenation | 3 | 2016 | 15 | 0.730 |
Why?
| | Bronchoscopy | 5 | 2016 | 8 | 0.730 |
Why?
| | Gestational Age | 12 | 2019 | 82 | 0.730 |
Why?
| | Drug Administration Schedule | 7 | 2018 | 45 | 0.730 |
Why?
| | Sample Size | 1 | 2017 | 3 | 0.730 |
Why?
| | Abnormalities, Multiple | 6 | 2018 | 33 | 0.730 |
Why?
| | Referral and Consultation | 1 | 2018 | 33 | 0.720 |
Why?
| | Cyanoacrylates | 1 | 2017 | 2 | 0.720 |
Why?
| | Administration, Oral | 9 | 2018 | 64 | 0.710 |
Why?
| | Diagnosis, Differential | 10 | 2021 | 78 | 0.710 |
Why?
| | Endoscopy, Gastrointestinal | 5 | 2019 | 21 | 0.710 |
Why?
| | Analgesics, Opioid | 5 | 2021 | 44 | 0.710 |
Why?
| | Ranitidine | 2 | 2015 | 5 | 0.710 |
Why?
| | Esophageal pH Monitoring | 3 | 2012 | 4 | 0.690 |
Why?
| | Quality of Life | 3 | 2021 | 96 | 0.690 |
Why?
| | Disease Management | 4 | 2021 | 38 | 0.690 |
Why?
| | Pancreatitis | 3 | 2012 | 6 | 0.680 |
Why?
| | Dissection | 2 | 2014 | 2 | 0.680 |
Why?
| | Pulmonary Emphysema | 2 | 2019 | 3 | 0.680 |
Why?
| | Device Removal | 4 | 2014 | 12 | 0.670 |
Why?
| | Cartilage Diseases | 1 | 2016 | 3 | 0.670 |
Why?
| | Joint Diseases | 1 | 2016 | 4 | 0.670 |
Why?
| | Health Resources | 2 | 2014 | 18 | 0.670 |
Why?
| | Fever | 2 | 2014 | 31 | 0.660 |
Why?
| | Pilonidal Sinus | 2 | 2019 | 4 | 0.660 |
Why?
| | Proctocolectomy, Restorative | 2 | 2020 | 4 | 0.650 |
Why?
| | Patient Readmission | 7 | 2020 | 70 | 0.650 |
Why?
| | Refusal to Participate | 1 | 2016 | 1 | 0.650 |
Why?
| | Radiography, Interventional | 1 | 2016 | 1 | 0.640 |
Why?
| | Fluid Therapy | 1 | 2016 | 5 | 0.640 |
Why?
| | High-Frequency Ventilation | 2 | 2016 | 7 | 0.640 |
Why?
| | Pancreatectomy | 2 | 2013 | 3 | 0.640 |
Why?
| | Rectum | 5 | 2019 | 21 | 0.630 |
Why?
| | Hospital Costs | 3 | 2016 | 27 | 0.630 |
Why?
| | Body Mass Index | 7 | 2016 | 125 | 0.630 |
Why?
| | Emergency Service, Hospital | 6 | 2020 | 135 | 0.630 |
Why?
| | Nervous System Diseases | 2 | 2014 | 16 | 0.630 |
Why?
| | Overweight | 3 | 2014 | 35 | 0.620 |
Why?
| | Intestinal Atresia | 3 | 2010 | 12 | 0.620 |
Why?
| | Meckel Diverticulum | 3 | 2018 | 8 | 0.610 |
Why?
| | Cost-Benefit Analysis | 6 | 2016 | 32 | 0.610 |
Why?
| | Patient Selection | 4 | 2021 | 46 | 0.610 |
Why?
| | Esophageal Sphincter, Lower | 1 | 2015 | 1 | 0.600 |
Why?
| | Dilatation | 1 | 2015 | 2 | 0.600 |
Why?
| | Gastric Fistula | 1 | 2015 | 3 | 0.600 |
Why?
| | Cutaneous Fistula | 1 | 2015 | 3 | 0.600 |
Why?
| | Anti-Infective Agents | 1 | 2015 | 15 | 0.590 |
Why?
| | Diagnostic Self Evaluation | 2 | 2021 | 3 | 0.590 |
Why?
| | Proton Pump Inhibitors | 1 | 2015 | 13 | 0.590 |
Why?
| | Gallstones | 2 | 2012 | 3 | 0.590 |
Why?
| | Predictive Value of Tests | 7 | 2019 | 101 | 0.580 |
Why?
| | Anastomosis, Surgical | 5 | 2010 | 14 | 0.580 |
Why?
| | Ileostomy | 2 | 2011 | 4 | 0.580 |
Why?
| | Apnea | 2 | 2012 | 5 | 0.570 |
Why?
| | Treatment Failure | 7 | 2019 | 21 | 0.570 |
Why?
| | Neutropenia | 2 | 2011 | 12 | 0.570 |
Why?
| | Vascular Access Devices | 1 | 2014 | 1 | 0.560 |
Why?
| | Needles | 1 | 2014 | 3 | 0.560 |
Why?
| | Equipment Failure | 1 | 2014 | 8 | 0.560 |
Why?
| | Prosthesis Implantation | 2 | 2010 | 4 | 0.550 |
Why?
| | Respiratory Aspiration | 1 | 2013 | 1 | 0.540 |
Why?
| | Postoperative Period | 7 | 2018 | 17 | 0.540 |
Why?
| | Pain Threshold | 1 | 2013 | 4 | 0.540 |
Why?
| | Debridement | 2 | 2012 | 5 | 0.530 |
Why?
| | Diaphragm | 2 | 2010 | 9 | 0.530 |
Why?
| | Contrast Media | 3 | 2014 | 21 | 0.530 |
Why?
| | Postoperative Nausea and Vomiting | 2 | 2013 | 5 | 0.530 |
Why?
| | Venous Thrombosis | 1 | 2013 | 1 | 0.520 |
Why?
| | Elective Surgical Procedures | 4 | 2018 | 14 | 0.520 |
Why?
| | Tietze's Syndrome | 1 | 2012 | 1 | 0.510 |
Why?
| | Therapeutic Equipoise | 1 | 2012 | 1 | 0.510 |
Why?
| | Cartilage | 1 | 2012 | 2 | 0.510 |
Why?
| | Internship and Residency | 3 | 2013 | 29 | 0.510 |
Why?
| | Abdominal Wall | 3 | 2020 | 7 | 0.510 |
Why?
| | Biopsy | 6 | 2019 | 54 | 0.510 |
Why?
| | Genital Diseases, Male | 1 | 2012 | 1 | 0.510 |
Why?
| | Comorbidity | 6 | 2017 | 66 | 0.500 |
Why?
| | Hemangioma | 1 | 2012 | 1 | 0.500 |
Why?
| | Splenic Neoplasms | 1 | 2012 | 2 | 0.500 |
Why?
| | Decision Making | 1 | 2013 | 32 | 0.500 |
Why?
| | Nod2 Signaling Adaptor Protein | 1 | 2012 | 4 | 0.500 |
Why?
| | Silver Sulfadiazine | 1 | 2012 | 5 | 0.500 |
Why?
| | Collagenases | 1 | 2012 | 5 | 0.500 |
Why?
| | Societies, Medical | 5 | 2017 | 40 | 0.500 |
Why?
| | Ovarian Cysts | 1 | 2012 | 3 | 0.500 |
Why?
| | Infant, Premature, Diseases | 4 | 2021 | 45 | 0.490 |
Why?
| | Cystadenoma, Mucinous | 1 | 2012 | 1 | 0.490 |
Why?
| | Practice Guidelines as Topic | 6 | 2021 | 98 | 0.490 |
Why?
| | Ovarian Neoplasms | 1 | 2012 | 8 | 0.480 |
Why?
| | Middle Aged | 7 | 2016 | 563 | 0.480 |
Why?
| | Heart Injuries | 1 | 2011 | 4 | 0.480 |
Why?
| | Cystic Adenomatoid Malformation of Lung, Congenital | 1 | 2011 | 1 | 0.480 |
Why?
| | Insufflation | 1 | 2011 | 3 | 0.480 |
Why?
| | Single-Blind Method | 4 | 2018 | 14 | 0.480 |
Why?
| | Lung Neoplasms | 3 | 2021 | 18 | 0.480 |
Why?
| | Monitoring, Physiologic | 1 | 2012 | 23 | 0.480 |
Why?
| | Personal Satisfaction | 2 | 2022 | 5 | 0.470 |
Why?
| | Anticoagulants | 2 | 2013 | 16 | 0.470 |
Why?
| | Adrenalectomy | 1 | 2011 | 2 | 0.470 |
Why?
| | Hospitalization | 6 | 2020 | 157 | 0.460 |
Why?
| | Thorax | 1 | 2011 | 4 | 0.460 |
Why?
| | Sports Equipment | 1 | 2011 | 2 | 0.460 |
Why?
| | Colectomy | 1 | 2011 | 10 | 0.460 |
Why?
| | Health Care Surveys | 5 | 2018 | 37 | 0.450 |
Why?
| | Accidents, Home | 1 | 2011 | 9 | 0.450 |
Why?
| | Enterocolitis | 2 | 2021 | 29 | 0.440 |
Why?
| | Iatrogenic Disease | 2 | 2010 | 6 | 0.440 |
Why?
| | Lung | 4 | 2021 | 90 | 0.440 |
Why?
| | Ossification, Heterotopic | 1 | 2010 | 2 | 0.440 |
Why?
| | Thymoma | 1 | 2010 | 2 | 0.440 |
Why?
| | Thymus Neoplasms | 1 | 2010 | 2 | 0.440 |
Why?
| | Jejunal Diseases | 1 | 2010 | 3 | 0.440 |
Why?
| | Therapeutic Irrigation | 3 | 2016 | 5 | 0.440 |
Why?
| | Periodicity | 1 | 2010 | 3 | 0.440 |
Why?
| | Duodenal Diseases | 1 | 2010 | 4 | 0.440 |
Why?
| | Reproducibility of Results | 8 | 2018 | 174 | 0.440 |
Why?
| | Fecal Incontinence | 3 | 2020 | 17 | 0.440 |
Why?
| | Decompression, Surgical | 1 | 2010 | 3 | 0.440 |
Why?
| | Nutritional Support | 1 | 2010 | 4 | 0.430 |
Why?
| | Xiphoid Bone | 1 | 2010 | 6 | 0.430 |
Why?
| | Adenomatous Polyposis Coli | 1 | 2010 | 23 | 0.430 |
Why?
| | Laparoscopes | 1 | 2010 | 1 | 0.430 |
Why?
| | Histamine H1 Antagonists | 1 | 2010 | 3 | 0.420 |
Why?
| | Digestive System Abnormalities | 2 | 2009 | 8 | 0.420 |
Why?
| | Cholangiopancreatography, Endoscopic Retrograde | 4 | 2018 | 5 | 0.420 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2010 | 5 | 0.420 |
Why?
| | Bezoars | 1 | 2009 | 3 | 0.420 |
Why?
| | Empyema | 2 | 2009 | 3 | 0.420 |
Why?
| | Ventriculoperitoneal Shunt | 1 | 2009 | 5 | 0.410 |
Why?
| | Ileocecal Valve | 1 | 2009 | 3 | 0.410 |
Why?
| | Parents | 3 | 2016 | 125 | 0.410 |
Why?
| | Intestinal Mucosa | 3 | 2019 | 37 | 0.410 |
Why?
| | Infant, Premature | 7 | 2021 | 118 | 0.400 |
Why?
| | Colon | 3 | 2015 | 13 | 0.400 |
Why?
| | Hemostatics | 1 | 2009 | 2 | 0.400 |
Why?
| | Thrombin | 1 | 2009 | 2 | 0.400 |
Why?
| | Wounds, Stab | 1 | 2009 | 2 | 0.400 |
Why?
| | Tibial Arteries | 1 | 2009 | 2 | 0.400 |
Why?
| | Ultrasonography, Interventional | 1 | 2009 | 4 | 0.400 |
Why?
| | Aneurysm, False | 1 | 2009 | 3 | 0.400 |
Why?
| | Longitudinal Studies | 4 | 2021 | 119 | 0.390 |
Why?
| | Survival Rate | 6 | 2021 | 79 | 0.390 |
Why?
| | Cholecystitis | 2 | 2008 | 6 | 0.390 |
Why?
| | Alkalosis | 1 | 2008 | 1 | 0.390 |
Why?
| | Hypokalemia | 1 | 2008 | 1 | 0.390 |
Why?
| | Pulmonary Blastoma | 2 | 2021 | 3 | 0.380 |
Why?
| | Regression Analysis | 4 | 2019 | 59 | 0.380 |
Why?
| | Hemorrhage | 2 | 2019 | 16 | 0.380 |
Why?
| | Braces | 2 | 2019 | 11 | 0.380 |
Why?
| | Pectus Carinatum | 2 | 2019 | 11 | 0.380 |
Why?
| | Anesthetics | 2 | 2021 | 4 | 0.380 |
Why?
| | Abdomen | 2 | 2009 | 5 | 0.380 |
Why?
| | Workload | 1 | 2008 | 7 | 0.380 |
Why?
| | Gentamicins | 1 | 2008 | 5 | 0.380 |
Why?
| | Missouri | 5 | 2018 | 90 | 0.380 |
Why?
| | Medical Staff, Hospital | 1 | 2008 | 5 | 0.380 |
Why?
| | Aged | 5 | 2015 | 300 | 0.370 |
Why?
| | Trauma Severity Indices | 4 | 2013 | 17 | 0.370 |
Why?
| | Patient Care Team | 1 | 2008 | 21 | 0.370 |
Why?
| | Anesthesia, Intravenous | 1 | 2008 | 1 | 0.370 |
Why?
| | Splenic Rupture | 1 | 2008 | 2 | 0.370 |
Why?
| | Milk, Human | 3 | 2019 | 19 | 0.370 |
Why?
| | Inflammatory Bowel Diseases | 2 | 2020 | 43 | 0.370 |
Why?
| | Cholecystectomy | 3 | 2013 | 8 | 0.370 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 2 | 2010 | 59 | 0.370 |
Why?
| | Gastrointestinal Hemorrhage | 1 | 2018 | 15 | 0.360 |
Why?
| | Duodenal Obstruction | 4 | 2008 | 8 | 0.360 |
Why?
| | Internal Fixators | 1 | 2007 | 3 | 0.360 |
Why?
| | Case-Control Studies | 5 | 2019 | 119 | 0.360 |
Why?
| | Hospital Charges | 3 | 2016 | 12 | 0.360 |
Why?
| | Antithrombin III | 1 | 2007 | 2 | 0.350 |
Why?
| | Disseminated Intravascular Coagulation | 1 | 2007 | 2 | 0.350 |
Why?
| | Hernia | 2 | 2018 | 4 | 0.350 |
Why?
| | Pain | 4 | 2020 | 44 | 0.350 |
Why?
| | Pneumonectomy | 3 | 2021 | 5 | 0.340 |
Why?
| | Logistic Models | 4 | 2019 | 95 | 0.340 |
Why?
| | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2021 | 33 | 0.340 |
Why?
| | Airway Obstruction | 3 | 2013 | 16 | 0.340 |
Why?
| | Aortic Aneurysm, Abdominal | 1 | 2006 | 1 | 0.340 |
Why?
| | Hypertension, Renovascular | 1 | 2006 | 3 | 0.340 |
Why?
| | Vascular Surgical Procedures | 1 | 2006 | 3 | 0.340 |
Why?
| | Blood Vessels | 1 | 2006 | 5 | 0.340 |
Why?
| | Gastrointestinal Diseases | 2 | 2017 | 52 | 0.330 |
Why?
| | Eating | 3 | 2021 | 31 | 0.330 |
Why?
| | Shock, Septic | 2 | 2021 | 4 | 0.330 |
Why?
| | Radiation Dosage | 3 | 2014 | 5 | 0.330 |
Why?
| | Ostomy | 2 | 2018 | 4 | 0.320 |
Why?
| | Rectal Prolapse | 2 | 2020 | 10 | 0.320 |
Why?
| | Forecasting | 2 | 2020 | 20 | 0.320 |
Why?
| | Infant, Newborn, Diseases | 3 | 2018 | 30 | 0.320 |
Why?
| | Multiple Trauma | 3 | 2013 | 13 | 0.320 |
Why?
| | Superior Mesenteric Artery Syndrome | 2 | 2020 | 5 | 0.310 |
Why?
| | Delivery, Obstetric | 1 | 2005 | 3 | 0.310 |
Why?
| | Pleura | 1 | 2005 | 1 | 0.310 |
Why?
| | Intention to Treat Analysis | 2 | 2018 | 9 | 0.310 |
Why?
| | Thoracic Injuries | 2 | 2021 | 9 | 0.310 |
Why?
| | Feasibility Studies | 4 | 2021 | 58 | 0.310 |
Why?
| | Spherocytosis, Hereditary | 2 | 2015 | 4 | 0.310 |
Why?
| | Guidelines as Topic | 2 | 2018 | 10 | 0.310 |
Why?
| | Duodenum | 2 | 2020 | 22 | 0.300 |
Why?
| | Urinary Diversion | 1 | 2005 | 1 | 0.300 |
Why?
| | Gastric Bypass | 1 | 2005 | 6 | 0.300 |
Why?
| | Hydrogen-Ion Concentration | 3 | 2011 | 19 | 0.300 |
Why?
| | Morbidity | 2 | 2016 | 10 | 0.300 |
Why?
| | Anemia, Sickle Cell | 2 | 2015 | 21 | 0.300 |
Why?
| | Electrolytes | 2 | 2016 | 6 | 0.300 |
Why?
| | Pilot Projects | 3 | 2019 | 116 | 0.300 |
Why?
| | Surgical Stomas | 2 | 2018 | 5 | 0.290 |
Why?
| | Recovery of Function | 3 | 2019 | 16 | 0.290 |
Why?
| | Colorectal Surgery | 2 | 2014 | 3 | 0.290 |
Why?
| | Gastrointestinal Tract | 2 | 2018 | 6 | 0.290 |
Why?
| | Bile Ducts, Extrahepatic | 1 | 2004 | 1 | 0.290 |
Why?
| | Pain Management | 2 | 2015 | 22 | 0.280 |
Why?
| | Prevalence | 4 | 2018 | 135 | 0.280 |
Why?
| | Chest Pain | 2 | 2021 | 5 | 0.280 |
Why?
| | ROC Curve | 2 | 2016 | 19 | 0.280 |
Why?
| | Enterocolitis, Pseudomembranous | 1 | 2004 | 4 | 0.280 |
Why?
| | Esthetics | 3 | 2013 | 7 | 0.280 |
Why?
| | Intraoperative Complications | 2 | 2015 | 4 | 0.280 |
Why?
| | Chemoembolization, Therapeutic | 1 | 2003 | 1 | 0.280 |
Why?
| | Hemangioendothelioma, Epithelioid | 1 | 2003 | 1 | 0.280 |
Why?
| | Plastics | 2 | 2014 | 2 | 0.280 |
Why?
| | Vomiting | 3 | 2020 | 22 | 0.280 |
Why?
| | Pneumonia | 3 | 2017 | 30 | 0.270 |
Why?
| | Liver Neoplasms | 1 | 2003 | 13 | 0.270 |
Why?
| | Splenic Diseases | 2 | 2017 | 2 | 0.270 |
Why?
| | Skin Transplantation | 2 | 2014 | 7 | 0.270 |
Why?
| | Liver Circulation | 1 | 2003 | 2 | 0.270 |
Why?
| | Rupture, Spontaneous | 3 | 2016 | 8 | 0.270 |
Why?
| | Registries | 3 | 2019 | 84 | 0.270 |
Why?
| | Reperfusion | 2 | 2002 | 2 | 0.260 |
Why?
| | Animals | 5 | 2021 | 861 | 0.260 |
Why?
| | Lethargy | 2 | 2013 | 2 | 0.260 |
Why?
| | Age Distribution | 4 | 2013 | 37 | 0.260 |
Why?
| | Injections, Intravenous | 2 | 2015 | 18 | 0.260 |
Why?
| | Hypoplastic Left Heart Syndrome | 2 | 2014 | 17 | 0.260 |
Why?
| | Chlorides | 2 | 2016 | 3 | 0.260 |
Why?
| | Prenatal Diagnosis | 5 | 2021 | 12 | 0.260 |
Why?
| | Bicarbonates | 2 | 2016 | 6 | 0.260 |
Why?
| | Clinical Competence | 2 | 2015 | 36 | 0.260 |
Why?
| | Propensity Score | 2 | 2021 | 10 | 0.250 |
Why?
| | Respiratory System Abnormalities | 2 | 2019 | 4 | 0.250 |
Why?
| | Equipment Design | 3 | 2014 | 12 | 0.250 |
Why?
| | Endoscopy | 2 | 2012 | 16 | 0.250 |
Why?
| | Tissue and Organ Procurement | 1 | 2002 | 17 | 0.250 |
Why?
| | Anthropometry | 2 | 2012 | 16 | 0.240 |
Why?
| | Surgeons | 3 | 2016 | 5 | 0.240 |
Why?
| | Craniocerebral Trauma | 2 | 2014 | 19 | 0.240 |
Why?
| | Masks | 1 | 2021 | 8 | 0.240 |
Why?
| | Community-Acquired Infections | 2 | 2011 | 9 | 0.240 |
Why?
| | Neurodevelopmental Disorders | 1 | 2021 | 12 | 0.240 |
Why?
| | Statistics, Nonparametric | 1 | 2021 | 20 | 0.230 |
Why?
| | Pleural Diseases | 3 | 2011 | 5 | 0.230 |
Why?
| | Phyllodes Tumor | 1 | 2021 | 2 | 0.230 |
Why?
| | Fibroadenoma | 1 | 2021 | 2 | 0.230 |
Why?
| | Mastectomy, Segmental | 1 | 2021 | 4 | 0.230 |
Why?
| | Sepsis | 2 | 2019 | 21 | 0.230 |
Why?
| | Hypothermia | 1 | 2021 | 2 | 0.230 |
Why?
| | Watchful Waiting | 1 | 2021 | 8 | 0.230 |
Why?
| | Breast Neoplasms | 1 | 2021 | 22 | 0.230 |
Why?
| | Anesthesia, General | 1 | 2021 | 1 | 0.230 |
Why?
| | Immunotherapy, Adoptive | 1 | 2021 | 5 | 0.230 |
Why?
| | Cholangiopancreatography, Magnetic Resonance | 2 | 2018 | 3 | 0.230 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2021 | 6 | 0.230 |
Why?
| | Kidney Transplantation | 1 | 2002 | 106 | 0.230 |
Why?
| | Respiratory Function Tests | 1 | 2020 | 19 | 0.230 |
Why?
| | Eosinophilia | 2 | 2019 | 22 | 0.220 |
Why?
| | Insurance Coverage | 1 | 2020 | 12 | 0.220 |
Why?
| | Patient Compliance | 2 | 2019 | 76 | 0.220 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2011 | 99 | 0.220 |
Why?
| | Motivation | 1 | 2021 | 66 | 0.220 |
Why?
| | Bacterial Infections | 1 | 2021 | 28 | 0.220 |
Why?
| | Heart Ventricles | 2 | 2018 | 32 | 0.220 |
Why?
| | Pregnancy | 4 | 2021 | 246 | 0.220 |
Why?
| | Echocardiography | 1 | 2020 | 58 | 0.220 |
Why?
| | Ligaments | 1 | 2020 | 4 | 0.220 |
Why?
| | Survival Analysis | 2 | 2018 | 47 | 0.220 |
Why?
| | Wound Closure Techniques | 1 | 2020 | 2 | 0.210 |
Why?
| | Constipation | 1 | 2020 | 15 | 0.210 |
Why?
| | Cross-Over Studies | 1 | 2020 | 31 | 0.210 |
Why?
| | Fibrinolysis | 1 | 2020 | 2 | 0.210 |
Why?
| | Skin | 1 | 2020 | 14 | 0.210 |
Why?
| | Pressure | 3 | 2019 | 13 | 0.210 |
Why?
| | Venous Thromboembolism | 1 | 2020 | 11 | 0.210 |
Why?
| | Thoracentesis | 1 | 2019 | 2 | 0.210 |
Why?
| | Probability | 3 | 2008 | 17 | 0.210 |
Why?
| | Gallbladder | 1 | 2019 | 4 | 0.210 |
Why?
| | Short Bowel Syndrome | 1 | 2019 | 4 | 0.210 |
Why?
| | Congenital Abnormalities | 3 | 2016 | 15 | 0.200 |
Why?
| | Manipulation, Orthopedic | 1 | 2019 | 6 | 0.200 |
Why?
| | Self Report | 1 | 2019 | 36 | 0.200 |
Why?
| | Conversion to Open Surgery | 2 | 2019 | 3 | 0.200 |
Why?
| | Sex Factors | 3 | 2014 | 77 | 0.200 |
Why?
| | Meconium | 2 | 2009 | 3 | 0.200 |
Why?
| | Infusions, Intravenous | 3 | 2021 | 24 | 0.200 |
Why?
| | Pancreatic Pseudocyst | 2 | 2009 | 3 | 0.200 |
Why?
| | Multicenter Studies as Topic | 2 | 2016 | 12 | 0.190 |
Why?
| | Thoracoplasty | 1 | 2018 | 1 | 0.190 |
Why?
| | Pain Perception | 1 | 2018 | 3 | 0.190 |
Why?
| | Anorexia | 1 | 2018 | 2 | 0.190 |
Why?
| | Surgical Instruments | 2 | 2010 | 4 | 0.190 |
Why?
| | Urinary Catheters | 1 | 2018 | 1 | 0.190 |
Why?
| | Pancreatic Ducts | 1 | 2018 | 2 | 0.190 |
Why?
| | Jejunum | 1 | 2018 | 7 | 0.190 |
Why?
| | Syndrome | 2 | 2016 | 30 | 0.190 |
Why?
| | Catheters, Indwelling | 1 | 2018 | 27 | 0.190 |
Why?
| | Analgesics | 1 | 2018 | 6 | 0.190 |
Why?
| | Postoperative Hemorrhage | 1 | 2018 | 1 | 0.190 |
Why?
| | Narcotics | 1 | 2018 | 9 | 0.190 |
Why?
| | Attitude to Health | 1 | 2018 | 35 | 0.190 |
Why?
| | Imaging, Three-Dimensional | 1 | 2018 | 9 | 0.190 |
Why?
| | Prostheses and Implants | 2 | 2011 | 8 | 0.190 |
Why?
| | Pelvic Neoplasms | 1 | 2018 | 3 | 0.190 |
Why?
| | Organs at Risk | 1 | 2018 | 3 | 0.190 |
Why?
| | Checklist | 1 | 2018 | 6 | 0.190 |
Why?
| | Fertility Preservation | 1 | 2018 | 5 | 0.190 |
Why?
| | Reference Standards | 1 | 2018 | 11 | 0.190 |
Why?
| | Analgesics, Non-Narcotic | 1 | 2018 | 8 | 0.180 |
Why?
| | Cost of Illness | 2 | 2008 | 14 | 0.180 |
Why?
| | Acetaminophen | 1 | 2018 | 21 | 0.180 |
Why?
| | Embolization, Therapeutic | 2 | 2017 | 11 | 0.180 |
Why?
| | Blood Gas Analysis | 2 | 2011 | 7 | 0.180 |
Why?
| | Magnets | 1 | 2017 | 2 | 0.180 |
Why?
| | Complementary Therapies | 1 | 2017 | 3 | 0.180 |
Why?
| | Gastroenterology | 1 | 2017 | 11 | 0.180 |
Why?
| | Ileitis | 1 | 2017 | 3 | 0.180 |
Why?
| | Counseling | 1 | 2018 | 64 | 0.180 |
Why?
| | Emergency Medical Services | 1 | 2017 | 18 | 0.170 |
Why?
| | Clostridium Infections | 1 | 2017 | 7 | 0.170 |
Why?
| | Hypotension | 1 | 2017 | 4 | 0.170 |
Why?
| | Body Weight | 2 | 2019 | 60 | 0.170 |
Why?
| | Trachea | 3 | 2017 | 14 | 0.170 |
Why?
| | Decision Support Techniques | 2 | 2015 | 11 | 0.170 |
Why?
| | Academic Medical Centers | 1 | 2016 | 10 | 0.170 |
Why?
| | Peritoneal Diseases | 1 | 2016 | 2 | 0.170 |
Why?
| | Program Development | 1 | 2016 | 18 | 0.170 |
Why?
| | Shock, Traumatic | 1 | 2016 | 2 | 0.170 |
Why?
| | Health Status Indicators | 1 | 2016 | 8 | 0.170 |
Why?
| | Vasoconstrictor Agents | 1 | 2016 | 3 | 0.170 |
Why?
| | Infant Formula | 2 | 2013 | 16 | 0.170 |
Why?
| | Weight Loss | 2 | 2008 | 36 | 0.170 |
Why?
| | Vocal Cord Paralysis | 2 | 2017 | 4 | 0.170 |
Why?
| | Surgicenters | 1 | 2016 | 2 | 0.170 |
Why?
| | Models, Organizational | 1 | 2016 | 9 | 0.160 |
Why?
| | Global Health | 1 | 2016 | 11 | 0.160 |
Why?
| | Surgical Flaps | 2 | 2019 | 6 | 0.160 |
Why?
| | False Negative Reactions | 2 | 2017 | 12 | 0.160 |
Why?
| | Medical Records | 1 | 2016 | 15 | 0.160 |
Why?
| | Volunteers | 1 | 2016 | 2 | 0.160 |
Why?
| | Comprehension | 1 | 2016 | 2 | 0.160 |
Why?
| | Potassium | 1 | 2016 | 8 | 0.160 |
Why?
| | Perception | 1 | 2016 | 10 | 0.160 |
Why?
| | Heparin | 2 | 2013 | 6 | 0.160 |
Why?
| | Child Health Services | 1 | 2016 | 27 | 0.160 |
Why?
| | Resuscitation | 1 | 2016 | 7 | 0.160 |
Why?
| | Granuloma, Plasma Cell | 1 | 2015 | 2 | 0.160 |
Why?
| | Evidence-Based Practice | 3 | 2021 | 12 | 0.160 |
Why?
| | Gastric Mucosa | 1 | 2015 | 14 | 0.160 |
Why?
| | Upper Gastrointestinal Tract | 1 | 2015 | 4 | 0.160 |
Why?
| | Attitude of Health Personnel | 2 | 2021 | 55 | 0.160 |
Why?
| | Odds Ratio | 2 | 2012 | 46 | 0.150 |
Why?
| | Hydromorphone | 1 | 2015 | 1 | 0.150 |
Why?
| | Fentanyl | 1 | 2015 | 1 | 0.150 |
Why?
| | Foreign-Body Reaction | 2 | 2007 | 3 | 0.150 |
Why?
| | Midazolam | 1 | 2015 | 11 | 0.150 |
Why?
| | Sarcoma, Ewing | 1 | 2015 | 4 | 0.150 |
Why?
| | Esophageal Stenosis | 2 | 2017 | 6 | 0.150 |
Why?
| | Cathartics | 1 | 2015 | 5 | 0.150 |
Why?
| | Canada | 2 | 2012 | 33 | 0.150 |
Why?
| | Amoxicillin-Potassium Clavulanate Combination | 1 | 2015 | 1 | 0.150 |
Why?
| | Osteosarcoma | 1 | 2015 | 26 | 0.150 |
Why?
| | Catheters | 1 | 2015 | 1 | 0.150 |
Why?
| | Remission, Spontaneous | 1 | 2015 | 2 | 0.150 |
Why?
| | Ankyrins | 1 | 2014 | 2 | 0.150 |
Why?
| | Gastroplasty | 1 | 2014 | 1 | 0.150 |
Why?
| | Rectal Diseases | 1 | 2014 | 2 | 0.150 |
Why?
| | Acute Chest Syndrome | 1 | 2014 | 3 | 0.150 |
Why?
| | Anemia, Hemolytic, Congenital | 1 | 2014 | 4 | 0.150 |
Why?
| | Benchmarking | 1 | 2014 | 10 | 0.150 |
Why?
| | Advisory Committees | 1 | 2014 | 9 | 0.150 |
Why?
| | Health Services Needs and Demand | 1 | 2014 | 17 | 0.150 |
Why?
| | Antineoplastic Agents | 2 | 2015 | 44 | 0.150 |
Why?
| | Apgar Score | 3 | 2019 | 6 | 0.150 |
Why?
| | Wounds, Penetrating | 1 | 2014 | 4 | 0.150 |
Why?
| | Electric Impedance | 2 | 2012 | 3 | 0.150 |
Why?
| | Diagnostic Techniques, Ophthalmological | 1 | 2014 | 2 | 0.150 |
Why?
| | Echocardiography, Transesophageal | 1 | 2014 | 9 | 0.150 |
Why?
| | Pupil | 1 | 2014 | 3 | 0.150 |
Why?
| | Reflex, Pupillary | 1 | 2014 | 3 | 0.150 |
Why?
| | Histological Techniques | 1 | 2014 | 1 | 0.150 |
Why?
| | Quality Indicators, Health Care | 1 | 2014 | 24 | 0.140 |
Why?
| | Heart | 1 | 2014 | 14 | 0.140 |
Why?
| | Rotation | 2 | 2020 | 5 | 0.140 |
Why?
| | Swine | 3 | 2003 | 16 | 0.140 |
Why?
| | Wound Healing | 2 | 2012 | 8 | 0.140 |
Why?
| | Residence Characteristics | 1 | 2014 | 35 | 0.140 |
Why?
| | Burns, Chemical | 1 | 2014 | 1 | 0.140 |
Why?
| | Burns, Electric | 1 | 2014 | 1 | 0.140 |
Why?
| | Foreign-Body Migration | 1 | 2014 | 1 | 0.140 |
Why?
| | Extravasation of Diagnostic and Therapeutic Materials | 1 | 2014 | 4 | 0.140 |
Why?
| | Seizures | 1 | 2014 | 29 | 0.140 |
Why?
| | Diagnostic Techniques, Digestive System | 2 | 2012 | 5 | 0.140 |
Why?
| | Blood Loss, Surgical | 2 | 2012 | 5 | 0.140 |
Why?
| | Tissue Donors | 3 | 2002 | 30 | 0.140 |
Why?
| | Solutions | 1 | 2013 | 4 | 0.140 |
Why?
| | Patients | 1 | 2013 | 2 | 0.140 |
Why?
| | Hematuria | 1 | 2013 | 4 | 0.140 |
Why?
| | Insurance, Health, Reimbursement | 2 | 2020 | 5 | 0.140 |
Why?
| | Respiratory Tract Infections | 1 | 2014 | 56 | 0.140 |
Why?
| | Urinalysis | 1 | 2013 | 7 | 0.140 |
Why?
| | Nephrectomy | 1 | 2013 | 13 | 0.140 |
Why?
| | Tertiary Care Centers | 1 | 2013 | 8 | 0.140 |
Why?
| | Respiratory Sounds | 1 | 2013 | 9 | 0.140 |
Why?
| | Oxycodone | 1 | 2013 | 3 | 0.140 |
Why?
| | Cough | 1 | 2013 | 7 | 0.140 |
Why?
| | Time | 1 | 2013 | 6 | 0.140 |
Why?
| | Appointments and Schedules | 1 | 2013 | 13 | 0.140 |
Why?
| | Symptom Assessment | 1 | 2013 | 10 | 0.130 |
Why?
| | Food | 1 | 2013 | 11 | 0.130 |
Why?
| | Remission Induction | 1 | 2013 | 23 | 0.130 |
Why?
| | Quality Assurance, Health Care | 1 | 2013 | 8 | 0.130 |
Why?
| | Interviews as Topic | 1 | 2013 | 37 | 0.130 |
Why?
| | Risk | 1 | 2013 | 27 | 0.130 |
Why?
| | Fraud | 1 | 2013 | 2 | 0.130 |
Why?
| | Authorship | 1 | 2013 | 3 | 0.130 |
Why?
| | Publishing | 1 | 2013 | 7 | 0.130 |
Why?
| | Walking | 1 | 2013 | 31 | 0.130 |
Why?
| | Venous Cutdown | 1 | 2013 | 1 | 0.130 |
Why?
| | Jugular Veins | 1 | 2013 | 3 | 0.130 |
Why?
| | Fellowships and Scholarships | 1 | 2013 | 16 | 0.130 |
Why?
| | Diet | 1 | 2013 | 47 | 0.130 |
Why?
| | Enoxaparin | 1 | 2013 | 3 | 0.130 |
Why?
| | Ileus | 2 | 2009 | 3 | 0.130 |
Why?
| | Ethics, Research | 1 | 2012 | 2 | 0.130 |
Why?
| | Organ Specificity | 2 | 2011 | 23 | 0.130 |
Why?
| | Muscle, Smooth | 1 | 2012 | 3 | 0.130 |
Why?
| | Body Size | 1 | 2012 | 8 | 0.130 |
Why?
| | Organ Size | 1 | 2012 | 19 | 0.130 |
Why?
| | Hospitals, Teaching | 1 | 2012 | 6 | 0.130 |
Why?
| | Polymyxins | 1 | 2012 | 3 | 0.130 |
Why?
| | Wound Infection | 1 | 2012 | 4 | 0.130 |
Why?
| | Administration, Topical | 1 | 2012 | 6 | 0.130 |
Why?
| | Inguinal Canal | 2 | 2015 | 3 | 0.120 |
Why?
| | Ointments | 1 | 2012 | 6 | 0.120 |
Why?
| | Drug Costs | 1 | 2012 | 5 | 0.120 |
Why?
| | Education, Medical | 1 | 2012 | 3 | 0.120 |
Why?
| | Uncertainty | 1 | 2012 | 4 | 0.120 |
Why?
| | Hypoxia, Brain | 1 | 2012 | 2 | 0.120 |
Why?
| | Sex Distribution | 2 | 2012 | 19 | 0.120 |
Why?
| | Ultrasonography, Prenatal | 1 | 2012 | 7 | 0.120 |
Why?
| | Polytetrafluoroethylene | 1 | 2012 | 1 | 0.120 |
Why?
| | Diarrhea | 1 | 2012 | 16 | 0.120 |
Why?
| | Voice Quality | 1 | 2011 | 2 | 0.120 |
Why?
| | Thoracic Vertebrae | 1 | 2011 | 4 | 0.120 |
Why?
| | Sternum | 1 | 2011 | 6 | 0.120 |
Why?
| | Disease Susceptibility | 1 | 2011 | 9 | 0.120 |
Why?
| | Cerebral Palsy | 1 | 2012 | 13 | 0.120 |
Why?
| | Methylprednisolone | 1 | 2011 | 3 | 0.120 |
Why?
| | Neuroprotective Agents | 1 | 2011 | 3 | 0.120 |
Why?
| | Spinal Cord Injuries | 1 | 2011 | 3 | 0.120 |
Why?
| | Polymerase Chain Reaction | 1 | 2012 | 98 | 0.120 |
Why?
| | Biomarkers | 1 | 2012 | 117 | 0.120 |
Why?
| | Blister | 1 | 2011 | 2 | 0.120 |
Why?
| | Carbon Dioxide | 1 | 2011 | 9 | 0.120 |
Why?
| | Oximetry | 1 | 2011 | 9 | 0.120 |
Why?
| | Mediastinal Neoplasms | 1 | 2011 | 4 | 0.120 |
Why?
| | Wounds, Gunshot | 2 | 2014 | 17 | 0.120 |
Why?
| | Catheter-Related Infections | 1 | 2011 | 16 | 0.120 |
Why?
| | Personnel Selection | 1 | 2011 | 4 | 0.120 |
Why?
| | Reference Values | 1 | 2011 | 45 | 0.120 |
Why?
| | Colonic Pouches | 1 | 2011 | 1 | 0.110 |
Why?
| | Hand Injuries | 1 | 2011 | 2 | 0.110 |
Why?
| | Dermatofibrosarcoma | 1 | 2011 | 2 | 0.110 |
Why?
| | Early Diagnosis | 1 | 2011 | 35 | 0.110 |
Why?
| | Fibrin Tissue Adhesive | 2 | 2008 | 2 | 0.110 |
Why?
| | Bacteremia | 1 | 2011 | 27 | 0.110 |
Why?
| | Bronchial Fistula | 2 | 2008 | 3 | 0.110 |
Why?
| | Cross-Sectional Studies | 1 | 2012 | 263 | 0.110 |
Why?
| | Early Ambulation | 1 | 2011 | 3 | 0.110 |
Why?
| | Colitis | 1 | 2011 | 9 | 0.110 |
Why?
| | Skin Neoplasms | 1 | 2011 | 9 | 0.110 |
Why?
| | Bibliometrics | 1 | 2010 | 1 | 0.110 |
Why?
| | Journal Impact Factor | 1 | 2010 | 1 | 0.110 |
Why?
| | Cross-Cultural Comparison | 1 | 2010 | 3 | 0.110 |
Why?
| | Research | 1 | 2010 | 9 | 0.110 |
Why?
| | Neoadjuvant Therapy | 1 | 2010 | 4 | 0.110 |
Why?
| | Research Support as Topic | 1 | 2010 | 6 | 0.110 |
Why?
| | Periodicals as Topic | 1 | 2010 | 5 | 0.110 |
Why?
| | Patient Admission | 1 | 2010 | 9 | 0.110 |
Why?
| | Amoxicillin | 1 | 2010 | 4 | 0.110 |
Why?
| | Prosthesis Design | 1 | 2010 | 7 | 0.110 |
Why?
| | History, 20th Century | 1 | 2010 | 6 | 0.110 |
Why?
| | History, 21st Century | 1 | 2010 | 6 | 0.110 |
Why?
| | Abdominal Neoplasms | 1 | 2010 | 5 | 0.110 |
Why?
| | Coated Materials, Biocompatible | 2 | 2011 | 2 | 0.110 |
Why?
| | Gynecomastia | 1 | 2010 | 2 | 0.110 |
Why?
| | Mastectomy, Subcutaneous | 1 | 2010 | 2 | 0.110 |
Why?
| | Mammaplasty | 1 | 2010 | 2 | 0.110 |
Why?
| | Intestinal Diseases | 1 | 2010 | 5 | 0.110 |
Why?
| | Dyspnea | 2 | 2020 | 5 | 0.110 |
Why?
| | Diphenhydramine | 1 | 2010 | 2 | 0.110 |
Why?
| | Diagnostic Errors | 1 | 2010 | 10 | 0.110 |
Why?
| | Intestines | 1 | 2010 | 27 | 0.100 |
Why?
| | Attitude | 1 | 2010 | 15 | 0.100 |
Why?
| | Hydrocephalus | 1 | 2009 | 6 | 0.100 |
Why?
| | Leukemic Infiltration | 1 | 2009 | 4 | 0.100 |
Why?
| | Meconium Aspiration Syndrome | 1 | 2009 | 5 | 0.100 |
Why?
| | Cystic Fibrosis | 1 | 2009 | 14 | 0.100 |
Why?
| | Infarction | 1 | 2009 | 3 | 0.100 |
Why?
| | Professional Practice | 1 | 2009 | 5 | 0.100 |
Why?
| | Respiratory Distress Syndrome, Newborn | 2 | 2021 | 13 | 0.100 |
Why?
| | Duodenostomy | 1 | 2009 | 2 | 0.100 |
Why?
| | Jejunostomy | 1 | 2009 | 3 | 0.100 |
Why?
| | Adrenocortical Adenoma | 1 | 2009 | 2 | 0.100 |
Why?
| | Injections, Intralesional | 1 | 2009 | 2 | 0.100 |
Why?
| | Adrenal Cortex Neoplasms | 1 | 2009 | 3 | 0.100 |
Why?
| | Hypertension, Renal | 1 | 2009 | 5 | 0.100 |
Why?
| | Reconstructive Surgical Procedures | 2 | 2010 | 11 | 0.100 |
Why?
| | Peritoneal Cavity | 1 | 2008 | 3 | 0.100 |
Why?
| | Biliary Tract Diseases | 1 | 2008 | 4 | 0.100 |
Why?
| | Fecal Impaction | 1 | 2008 | 4 | 0.100 |
Why?
| | Perfusion | 3 | 2003 | 8 | 0.100 |
Why?
| | Dehydration | 1 | 2008 | 2 | 0.100 |
Why?
| | Accidents | 1 | 2008 | 6 | 0.100 |
Why?
| | Surgical Stapling | 1 | 2008 | 1 | 0.100 |
Why?
| | Goals | 1 | 2008 | 6 | 0.100 |
Why?
| | Infant Food | 1 | 2008 | 7 | 0.100 |
Why?
| | Failure to Thrive | 1 | 2008 | 7 | 0.100 |
Why?
| | Precancerous Conditions | 1 | 2008 | 4 | 0.100 |
Why?
| | Glucocorticoids | 1 | 2009 | 35 | 0.100 |
Why?
| | Peutz-Jeghers Syndrome | 1 | 2008 | 6 | 0.100 |
Why?
| | Midwestern United States | 2 | 2019 | 42 | 0.100 |
Why?
| | Hospitals | 2 | 2021 | 30 | 0.100 |
Why?
| | Duodenoscopy | 1 | 2008 | 3 | 0.090 |
Why?
| | Work Schedule Tolerance | 1 | 2008 | 5 | 0.090 |
Why?
| | Quality of Health Care | 1 | 2008 | 17 | 0.090 |
Why?
| | Arkansas | 2 | 2019 | 2 | 0.090 |
Why?
| | Oklahoma | 2 | 2019 | 4 | 0.090 |
Why?
| | Arizona | 2 | 2019 | 3 | 0.090 |
Why?
| | Texas | 2 | 2019 | 9 | 0.090 |
Why?
| | Multivariate Analysis | 1 | 2008 | 75 | 0.090 |
Why?
| | Cholangiography | 1 | 2008 | 2 | 0.090 |
Why?
| | Cystic Duct | 1 | 2008 | 2 | 0.090 |
Why?
| | Choledocholithiasis | 1 | 2008 | 2 | 0.090 |
Why?
| | Consensus | 2 | 2019 | 26 | 0.090 |
Why?
| | Personnel Staffing and Scheduling | 1 | 2008 | 18 | 0.090 |
Why?
| | Observation | 1 | 2008 | 3 | 0.090 |
Why?
| | Down Syndrome | 1 | 2008 | 27 | 0.090 |
Why?
| | Disease Progression | 1 | 2008 | 90 | 0.090 |
Why?
| | Surgical Equipment | 1 | 2007 | 1 | 0.090 |
Why?
| | Wandering Spleen | 1 | 2007 | 1 | 0.090 |
Why?
| | Cysts | 1 | 2007 | 3 | 0.090 |
Why?
| | Anastomotic Leak | 2 | 2017 | 3 | 0.090 |
Why?
| | Silk | 1 | 2007 | 1 | 0.090 |
Why?
| | Spinal Diseases | 1 | 2007 | 2 | 0.090 |
Why?
| | Urinary Tract | 1 | 2007 | 5 | 0.090 |
Why?
| | Gram-Positive Bacterial Infections | 1 | 2007 | 8 | 0.090 |
Why?
| | Mullerian Ducts | 1 | 2006 | 4 | 0.080 |
Why?
| | Uterus | 1 | 2006 | 9 | 0.080 |
Why?
| | In Vitro Techniques | 2 | 2003 | 32 | 0.080 |
Why?
| | Relative Value Scales | 1 | 2006 | 2 | 0.080 |
Why?
| | Urachus | 1 | 2005 | 3 | 0.080 |
Why?
| | Urinary Bladder | 1 | 2005 | 7 | 0.080 |
Why?
| | Urethra | 1 | 2005 | 5 | 0.080 |
Why?
| | Respiration, Artificial | 2 | 2019 | 31 | 0.080 |
Why?
| | Cesarean Section | 1 | 2005 | 4 | 0.080 |
Why?
| | Hemolysis | 2 | 2002 | 4 | 0.080 |
Why?
| | Bandages, Hydrocolloid | 1 | 2005 | 1 | 0.080 |
Why?
| | Bilirubin | 2 | 2015 | 14 | 0.080 |
Why?
| | Ischemia | 2 | 2002 | 6 | 0.080 |
Why?
| | Hypospadias | 1 | 2005 | 3 | 0.080 |
Why?
| | Hemoglobins | 2 | 2015 | 24 | 0.080 |
Why?
| | Obesity, Morbid | 1 | 2005 | 9 | 0.070 |
Why?
| | Laryngoscopy | 2 | 2017 | 3 | 0.070 |
Why?
| | Dilatation, Pathologic | 1 | 2004 | 6 | 0.070 |
Why?
| | Mitomycin | 1 | 2003 | 1 | 0.070 |
Why?
| | Cisplatin | 1 | 2003 | 6 | 0.070 |
Why?
| | Doxorubicin | 1 | 2003 | 16 | 0.070 |
Why?
| | Allopurinol | 1 | 2003 | 1 | 0.070 |
Why?
| | Raffinose | 1 | 2003 | 1 | 0.070 |
Why?
| | Organ Preservation Solutions | 1 | 2003 | 1 | 0.070 |
Why?
| | Tissue and Organ Harvesting | 1 | 2003 | 2 | 0.070 |
Why?
| | Models, Animal | 1 | 2003 | 7 | 0.070 |
Why?
| | Urea | 1 | 2003 | 12 | 0.070 |
Why?
| | Glutathione | 1 | 2003 | 13 | 0.070 |
Why?
| | Adenosine | 1 | 2003 | 9 | 0.070 |
Why?
| | Osteogenesis | 1 | 2003 | 10 | 0.070 |
Why?
| | Homeostasis | 1 | 2003 | 16 | 0.070 |
Why?
| | Palliative Care | 2 | 2014 | 16 | 0.060 |
Why?
| | Insulin | 1 | 2003 | 47 | 0.060 |
Why?
| | Bile | 1 | 2002 | 16 | 0.060 |
Why?
| | Fatty Liver | 1 | 2002 | 5 | 0.060 |
Why?
| | Hepatocytes | 1 | 2002 | 7 | 0.060 |
Why?
| | Hot Temperature | 1 | 2002 | 4 | 0.060 |
Why?
| | Cold Temperature | 1 | 2002 | 3 | 0.060 |
Why?
| | Hemodynamics | 1 | 2002 | 11 | 0.060 |
Why?
| | Cryopreservation | 1 | 2002 | 5 | 0.060 |
Why?
| | Intensive Care Units | 1 | 2022 | 14 | 0.060 |
Why?
| | Photography | 1 | 2021 | 4 | 0.060 |
Why?
| | Anal Canal | 1 | 2021 | 18 | 0.060 |
Why?
| | Infant, Extremely Low Birth Weight | 1 | 2021 | 17 | 0.060 |
Why?
| | Outpatients | 1 | 2021 | 22 | 0.060 |
Why?
| | Lipid Metabolism | 1 | 2001 | 8 | 0.060 |
Why?
| | Ultrasonography, Mammary | 1 | 2021 | 2 | 0.060 |
Why?
| | Biopsy, Large-Core Needle | 1 | 2021 | 3 | 0.060 |
Why?
| | Breast | 1 | 2021 | 4 | 0.060 |
Why?
| | Ribonuclease III | 1 | 2021 | 2 | 0.060 |
Why?
| | DEAD-box RNA Helicases | 1 | 2021 | 2 | 0.060 |
Why?
| | Neoplasm Metastasis | 1 | 2021 | 15 | 0.060 |
Why?
| | Insurance Benefits | 1 | 2020 | 1 | 0.060 |
Why?
| | BK Virus | 1 | 2021 | 3 | 0.060 |
Why?
| | Mucormycosis | 1 | 2021 | 3 | 0.060 |
Why?
| | Hospitals, University | 1 | 2020 | 3 | 0.060 |
Why?
| | Infusion Pumps | 1 | 2021 | 5 | 0.060 |
Why?
| | Cell Line, Tumor | 1 | 2021 | 60 | 0.060 |
Why?
| | Medicaid | 1 | 2020 | 25 | 0.050 |
Why?
| | Nausea | 1 | 2020 | 13 | 0.050 |
Why?
| | Blood Component Transfusion | 1 | 2020 | 2 | 0.050 |
Why?
| | Plasma | 1 | 2020 | 6 | 0.050 |
Why?
| | Mutation | 1 | 2021 | 195 | 0.050 |
Why?
| | Parenteral Nutrition | 1 | 2019 | 4 | 0.050 |
Why?
| | Infant, Low Birth Weight | 1 | 2019 | 13 | 0.050 |
Why?
| | Age of Onset | 2 | 2013 | 22 | 0.050 |
Why?
| | Shock | 1 | 2019 | 4 | 0.050 |
Why?
| | Prolapse | 1 | 2018 | 4 | 0.050 |
Why?
| | Aorta, Thoracic | 1 | 2018 | 10 | 0.050 |
Why?
| | Preoperative Period | 1 | 2018 | 5 | 0.050 |
Why?
| | Primary Ovarian Insufficiency | 1 | 2018 | 3 | 0.050 |
Why?
| | Puberty | 1 | 2018 | 6 | 0.050 |
Why?
| | Program Evaluation | 1 | 2018 | 49 | 0.050 |
Why?
| | Biliary Atresia | 1 | 2017 | 2 | 0.050 |
Why?
| | Urinary Tract Infections | 1 | 2018 | 23 | 0.040 |
Why?
| | Angiography | 1 | 2017 | 8 | 0.040 |
Why?
| | Infant Care | 1 | 2017 | 5 | 0.040 |
Why?
| | Recurrent Laryngeal Nerve Injuries | 1 | 2017 | 1 | 0.040 |
Why?
| | Rare Diseases | 1 | 2017 | 7 | 0.040 |
Why?
| | Tennessee | 1 | 2017 | 2 | 0.040 |
Why?
| | Parenteral Nutrition, Total | 1 | 2017 | 7 | 0.040 |
Why?
| | Tracheostomy | 1 | 2017 | 18 | 0.040 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2017 | 40 | 0.040 |
Why?
| | Exercise | 1 | 2018 | 102 | 0.040 |
Why?
| | Vancomycin | 1 | 2017 | 17 | 0.040 |
Why?
| | Peritonitis | 1 | 2017 | 53 | 0.040 |
Why?
| | Asymptomatic Diseases | 1 | 2016 | 5 | 0.040 |
Why?
| | Cooperative Behavior | 1 | 2016 | 26 | 0.040 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2015 | 2 | 0.040 |
Why?
| | Ligation | 1 | 2015 | 5 | 0.040 |
Why?
| | Reticulocyte Count | 1 | 2015 | 1 | 0.040 |
Why?
| | Atrophy | 1 | 2015 | 4 | 0.040 |
Why?
| | Reticulocytes | 1 | 2014 | 3 | 0.040 |
Why?
| | Intra-Abdominal Hypertension | 1 | 2014 | 3 | 0.040 |
Why?
| | Thinness | 1 | 2014 | 7 | 0.040 |
Why?
| | Analysis of Variance | 1 | 2014 | 28 | 0.040 |
Why?
| | Regional Medical Programs | 1 | 2014 | 1 | 0.040 |
Why?
| | Hospitals, High-Volume | 1 | 2014 | 2 | 0.040 |
Why?
| | Appendiceal Neoplasms | 1 | 2014 | 2 | 0.040 |
Why?
| | Carcinoid Tumor | 1 | 2014 | 2 | 0.040 |
Why?
| | Cecal Diseases | 1 | 2014 | 2 | 0.040 |
Why?
| | Intestinal Neoplasms | 1 | 2014 | 2 | 0.040 |
Why?
| | Enterobiasis | 1 | 2014 | 2 | 0.040 |
Why?
| | Kansas | 1 | 2014 | 47 | 0.040 |
Why?
| | Granuloma | 1 | 2014 | 4 | 0.040 |
Why?
| | Anesthesia | 1 | 2014 | 4 | 0.040 |
Why?
| | Incidental Findings | 1 | 2014 | 8 | 0.040 |
Why?
| | Respiratory Tract Diseases | 1 | 2014 | 9 | 0.030 |
Why?
| | Electronic Health Records | 1 | 2014 | 53 | 0.030 |
Why?
| | Multiple Birth Offspring | 1 | 2013 | 3 | 0.030 |
Why?
| | Competitive Behavior | 1 | 2013 | 2 | 0.030 |
Why?
| | Job Application | 1 | 2013 | 2 | 0.030 |
Why?
| | Feces | 1 | 2013 | 34 | 0.030 |
Why?
| | Confidence Intervals | 1 | 2012 | 15 | 0.030 |
Why?
| | Pleural Cavity | 1 | 2012 | 1 | 0.030 |
Why?
| | Deoxyribonucleases | 1 | 2012 | 2 | 0.030 |
Why?
| | Expectorants | 1 | 2012 | 2 | 0.030 |
Why?
| | Enterostomy | 1 | 2012 | 2 | 0.030 |
Why?
| | Pneumonia, Bacterial | 1 | 2012 | 3 | 0.030 |
Why?
| | Probiotics | 1 | 2012 | 8 | 0.030 |
Why?
| | Temperature | 2 | 2002 | 11 | 0.030 |
Why?
| | Tracheotomy | 1 | 2011 | 2 | 0.030 |
Why?
| | Disinfection | 1 | 2011 | 1 | 0.030 |
Why?
| | Chlorhexidine | 1 | 2011 | 2 | 0.030 |
Why?
| | Povidone-Iodine | 1 | 2011 | 2 | 0.030 |
Why?
| | Meta-Analysis as Topic | 1 | 2011 | 6 | 0.030 |
Why?
| | Bandages | 1 | 2011 | 3 | 0.030 |
Why?
| | Anti-Infective Agents, Local | 1 | 2011 | 6 | 0.030 |
Why?
| | Ethanol | 1 | 2011 | 6 | 0.030 |
Why?
| | Mediastinum | 1 | 2011 | 5 | 0.030 |
Why?
| | Lymphoma | 1 | 2011 | 6 | 0.030 |
Why?
| | Cardiac Surgical Procedures | 1 | 2011 | 21 | 0.030 |
Why?
| | Leukemia | 1 | 2011 | 14 | 0.030 |
Why?
| | Statistics as Topic | 1 | 2011 | 17 | 0.030 |
Why?
| | Foundations | 1 | 2010 | 1 | 0.030 |
Why?
| | United States Public Health Service | 1 | 2010 | 1 | 0.030 |
Why?
| | Committee Membership | 1 | 2010 | 1 | 0.030 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2010 | 3 | 0.030 |
Why?
| | Electronic Mail | 1 | 2010 | 2 | 0.030 |
Why?
| | Financial Support | 1 | 2010 | 2 | 0.030 |
Why?
| | Data Collection | 1 | 2010 | 35 | 0.030 |
Why?
| | Constriction, Pathologic | 1 | 2010 | 6 | 0.030 |
Why?
| | Gastrointestinal Motility | 1 | 2010 | 7 | 0.030 |
Why?
| | Nipples | 1 | 2010 | 2 | 0.030 |
Why?
| | Diatrizoate Meglumine | 1 | 2009 | 1 | 0.030 |
Why?
| | Hypertrophy | 1 | 2009 | 4 | 0.030 |
Why?
| | Omentum | 1 | 2009 | 4 | 0.030 |
Why?
| | Pneumoperitoneum | 1 | 2009 | 3 | 0.030 |
Why?
| | Hospital Mortality | 1 | 2009 | 23 | 0.030 |
Why?
| | Hamartoma | 1 | 2008 | 4 | 0.020 |
Why?
| | Pregnancy in Diabetics | 1 | 2008 | 2 | 0.020 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2008 | 38 | 0.020 |
Why?
| | Esophageal Fistula | 1 | 2008 | 2 | 0.020 |
Why?
| | Thoracic Neoplasms | 1 | 2008 | 2 | 0.020 |
Why?
| | Respiratory Tract Fistula | 1 | 2008 | 2 | 0.020 |
Why?
| | Hemothorax | 1 | 2008 | 3 | 0.020 |
Why?
| | Scoliosis | 1 | 2008 | 4 | 0.020 |
Why?
| | Aspergillosis | 1 | 2007 | 1 | 0.020 |
Why?
| | Lung Diseases, Fungal | 1 | 2007 | 1 | 0.020 |
Why?
| | Operating Rooms | 1 | 2007 | 4 | 0.020 |
Why?
| | Pharmacy Service, Hospital | 1 | 2007 | 8 | 0.020 |
Why?
| | Emergencies | 1 | 2007 | 12 | 0.020 |
Why?
| | Chi-Square Distribution | 1 | 2007 | 35 | 0.020 |
Why?
| | Peptostreptococcus | 1 | 2007 | 1 | 0.020 |
Why?
| | Cystectomy | 1 | 2007 | 1 | 0.020 |
Why?
| | Pelvis | 1 | 2007 | 2 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2008 | 145 | 0.020 |
Why?
| | Neoplasms | 1 | 2008 | 87 | 0.020 |
Why?
| | Disorders of Sex Development | 1 | 2006 | 5 | 0.020 |
Why?
| | Urination | 1 | 2005 | 2 | 0.020 |
Why?
| | Diagnostic Tests, Routine | 1 | 2005 | 19 | 0.020 |
Why?
| | Health Care Costs | 1 | 2005 | 33 | 0.020 |
Why?
| | Costs and Cost Analysis | 1 | 2005 | 8 | 0.020 |
Why?
| | Causality | 1 | 2003 | 10 | 0.020 |
Why?
| | Kinetics | 1 | 2002 | 35 | 0.020 |
Why?
| | Hypothermia, Induced | 1 | 2001 | 6 | 0.010 |
Why?
| | Liver Function Tests | 1 | 2001 | 5 | 0.010 |
Why?
|
|
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|